Cargando…
O-GlcNAc modification forces the formation of an α-Synuclein amyloid-strain with notably diminished seeding activity and pathology
The process of amyloid fibril formation remains one of the primary targets for developing diagnostics and treatments for several neurodegenerative diseases (NDDs). Amyloid-forming proteins such α-Synuclein and Tau, which are implicated in the pathogenesis of Alzheimer’s and Parkinson’s disease, can...
Autores principales: | Balana, Aaron T., Mahul-Mellier, Anne-Laure, Nguyen, Binh A, Horvath, Mian, Javed, Afraah, Hard, Eldon R., Jasiqi, Yllza, Singh, Preeti, Afrin, Shumaila, Pedretti, Rose, Singh, Virender, Lee, Virginia M.-Y., Luk, Kelvin C., Saelices, Lorena, Lashuel, Hilal A., Pratt, Matthew R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028859/ https://www.ncbi.nlm.nih.gov/pubmed/36945566 http://dx.doi.org/10.1101/2023.03.07.531573 |
Ejemplares similares
-
Methods for Studying Site-Specific O-GlcNAc
Modifications: Successes, Limitations, and Important Future Goals
por: Moon, Stuart P., et al.
Publicado: (2021) -
O-GlcNAc
Modification Alters the Chaperone
Activity of HSP27 Charcot-Marie-Tooth Type 2 (CMT2) Variants in a
Mutation-Selective Fashion
por: Moon, Stuart P., et al.
Publicado: (2023) -
4-Deoxy-4-fluoro-GalNAz (4FGalNAz) Is a Metabolic
Chemical Reporter of O-GlcNAc Modifications, Highlighting the
Notable Substrate Flexibility of O-GlcNAc Transferase
por: Jackson, Emma G., et al.
Publicado: (2021) -
X-inactivation normalizes O-GlcNAc transferase levels and generates an O-GlcNAc-depleted Barr body
por: Olivier-Van Stichelen, Stéphanie, et al.
Publicado: (2014) -
Proteolysis of HCF-1 by Ser/Thr glycosylation-incompetent O-GlcNAc transferase:UDP-GlcNAc complexes
por: Kapuria, Vaibhav, et al.
Publicado: (2016)